➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Mallinckrodt
Merck
AstraZeneca
Express Scripts

Last Updated: March 3, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Carisbamate

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Carisbamate?

Carisbamate is an investigational drug.

There have been 14 clinical trials for Carisbamate. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2009.

The most common disease conditions in clinical trials are Epilepsy, Epilepsies, Partial, and Seizures. The leading clinical trial sponsors are SK Life Science, SK Life Science, Inc., and Baylor College of Medicine.

Recent Clinical Trials for Carisbamate
TitleSponsorPhase
Bioavailability and Food Effect Study of 3 Types of CarisbamatePRA Health SciencesPhase 1
Bioavailability and Food Effect Study of 3 Types of CarisbamateSK Life Science, Inc.Phase 1
Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut SyndromeSK Life Science, Inc.Phase 1

See all Carisbamate clinical trials

Clinical Trial Summary for Carisbamate

Top disease conditions for Carisbamate
Top clinical trial sponsors for Carisbamate

See all Carisbamate clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Mallinckrodt
Merck
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.